Advertisement

Topics

Phase III Trial With Zepsyre® in Small-Cell Lung Cancer (ATLANTIS) to Continue on the Basis of ...

08:30 EST 15 Nov 2017 | BioMedReports - Blog

The IDMC's recommendation came after an analysis of the safety data obtained with the first 150 patients treated in the trial. This pivotal randomised Phase

Read more...

Original Article: Phase III Trial With Zepsyre® in Small-Cell Lung Cancer (ATLANTIS) to Continue on the Basis of ...

NEXT ARTICLE

More From BioPortfolio on "Phase III Trial With Zepsyre® in Small-Cell Lung Cancer (ATLANTIS) to Continue on the Basis of ..."

Advertisement
Quick Search
Advertisement
Advertisement